Posaconazole, serum or plasma-994
Test info
Posaconazole, serum or plasma
994
LAB994
MSO
Noxafil
Prophylaxis of invasive Aspergillus and Candida infections in severely immunocompromised patients and treatments of oropharyngeal candidiasis
Specimen
Serum
1.0 mL
0.5 mL
Do not use a gel barrier tube.
The use of gel-barrier tubes is not recommended due to slow absorption of the drug by the gel. Depending upon the specimen volume and storage times, the decrease in drug level due to absorption may be clinically significant.
- Allow sample to clot
- Spin
- Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum, within two (2) hours of sample collection
EDTA plasma
Immediately following collection, mix sample thoroughly by gently inverting 8 - 10 times to prevent clotting
- Spin
- Transfer plasma to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as EDTA plasma, within two (2) hours of sample collection
Refrigerated (preferred) - 14 days
Ambient - 14 days
Frozen - 14 days
Performance
LabCorp Burlington (700265): R-NX
Mo - Fr
8 days
Liquid chromatography/tandem mass spectrometry (LC/MS-MS)
Clinical and Interpretive info
An interpretive report will be provided
Billing
80187
Result 53731-6
Tracking
05/24/2019
04/06/2022
04/06/2022